Back
Acurx Pharmaceuticals Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
24
ACXP
Acurx Pharmaceuticals
Last Price:
$0.39
Seasonality Move:
-12.49%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and ACXP is experiencing selling pressure, which indicates risk of future bearish movement.
Acurx Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.39 | Sell |
20-day SMA: | 0.39 | Sell |
50-day SMA: | 0.43 | Sell |
200-day SMA: | 1.25 | Sell |
8-day EMA: | 0.38 | Sell |
20-day EMA: | 0.39 | Sell |
50-day EMA: | 0.46 | Sell |
200-day EMA: | 1.13 | Sell |
Acurx Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 41.46 | Sell |
Chaikin Money Flow: | -93750 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.34 - 0.4) | Sell |
Bollinger Bands (100): | (0.4 - 0.82) | Sell |
Acurx Pharmaceuticals Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Acurx Pharmaceuticals Stock
Is Acurx Pharmaceuticals Stock a Buy?
-
Acurx Pharmaceuticals share price is 0.36 while ACXP 8-day simple moving average is 0.39, which is a Sell signal.
-
The stock price of ACXP is 0.36 while Acurx Pharmaceuticals 20-day SMA is 0.39, which makes it a Sell.
-
Acurx Pharmaceuticals 50-day simple moving average is 0.43 while ACXP share price is 0.36, making it a Sell technically.
-
ACXP stock price is 0.36 and Acurx Pharmaceuticals 200-day simple moving average is 1.25, creating a Sell signal.
ACXP Technical Analysis vs Fundamental Analysis
Sell
24
Acurx Pharmaceuticals (ACXP)
is a Sell
Is Acurx Pharmaceuticals a Buy or a Sell?
-
Acurx Pharmaceuticals stock is rated a SellThe current Acurx Pharmaceuticals [ACXP] share price is $0.36. The Score for ACXP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Acurx Pharmaceuticals Stock Info
Market Cap:
7.9M
Price in USD:
0.36
Share Volume:
134.1K
Acurx Pharmaceuticals 52-Week Range
52-Week High:
3.33
52-Week Low:
0.30
Sell
24
Acurx Pharmaceuticals (ACXP)
is a Sell
Acurx Pharmaceuticals Share Price Forecast
-
What is the Acurx Pharmaceuticals stock price today?The Acurx Pharmaceuticals stock price is 0.36 USD today.
-
Will ACXP stock go up or go down?Acurx Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Acurx Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acurx Pharmaceuticals is overvalued.
Is Acurx Pharmaceuticals Stock a Buy?
-
Acurx Pharmaceuticals share price is 0.36 while ACXP 8-day exponential moving average is 0.38, which is a Sell signal.
-
The stock price of ACXP is 0.36 while Acurx Pharmaceuticals 20-day EMA is 0.39, which makes it a Sell.
-
Acurx Pharmaceuticals 50-day exponential moving average is 0.46 while ACXP share price is 0.36, making it a Sell technically.
-
ACXP stock price is 0.36 and Acurx Pharmaceuticals 200-day simple moving average is 1.13, creating a Sell signal.
Fundamental Analysis of Acurx Pharmaceuticals
Is Acurx Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.20 per share.
Technical Analysis of Acurx Pharmaceuticals
Should I short Acurx Pharmaceuticals stock?
-
ACXP Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Acurx Pharmaceuticals is a Sell
-
Acurx Pharmaceuticals Relative Strength Index (RSI) is 41.46, which suggest Acurx Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Acurx Pharmaceuticals is (0.34 - 0.4), which suggest Acurx Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Acurx Pharmaceuticals is (0.4 - 0.82), which suggest Acurx Pharmaceuticals is a Sell
* Acurx Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.